331 related articles for article (PubMed ID: 23905231)
1. Nurses must report adverse drug reactions.
Griffith R
Br J Nurs; 2013 Apr 25-May 8; 22(8):484-5. PubMed ID: 23905231
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
3. Reporting of adverse drug reactions by nurses.
Morrison-Griffiths S; Walley TJ; Park BK; Breckenridge AM; Pirmohamed M
Lancet; 2003 Apr; 361(9366):1347-8. PubMed ID: 12711472
[TBL] [Abstract][Full Text] [Related]
4. [Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
Krähenbühl S
Ther Umsch; 2015 Dec; 72(11-12):669-71. PubMed ID: 26654809
[TBL] [Abstract][Full Text] [Related]
5. Pharmacovigilance and communicating safety information.
Drug Ther Bull; 2012 Dec; 50(12):138-40. PubMed ID: 23241564
[TBL] [Abstract][Full Text] [Related]
6. An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals.
Rehan HS; Chopra D; Holani SN; Mishra R
Int J Risk Saf Med; 2014; 26(1):1-8. PubMed ID: 24796346
[TBL] [Abstract][Full Text] [Related]
7. A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.
Lorimer S; Cox A; Langford NJ
J Clin Pharm Ther; 2012 Apr; 37(2):148-52. PubMed ID: 21592157
[TBL] [Abstract][Full Text] [Related]
8. [Direct reporting by patients of adverse drug reactions in Spain].
Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
[TBL] [Abstract][Full Text] [Related]
9. Nurse reporting of adverse events caused by medicines.
Hunt JM; Gjoka G
Nurs Times; 2003 Dec 9-15; 99(49):24-5. PubMed ID: 14705341
[TBL] [Abstract][Full Text] [Related]
10. Identifying and managing adverse drug reactions: Qualitative analysis of patient reports to the UK yellow card scheme.
O' Donovan B; Rodgers RM; Cox AR; Krska J
Br J Clin Pharmacol; 2022 Jul; 88(7):3434-3446. PubMed ID: 35128732
[TBL] [Abstract][Full Text] [Related]
11. [Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)].
Eckhardt K; Cremer-Schaeffer P; König J; Paeschke N
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):173-80. PubMed ID: 15726458
[TBL] [Abstract][Full Text] [Related]
12. Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media.
Ghosh R; Lewis D
Expert Opin Drug Saf; 2015; 14(12):1845-53. PubMed ID: 26436834
[TBL] [Abstract][Full Text] [Related]
13. A review of the National pharmacovigilance system in Malta - implementing and operating a pharmacovigilance management system.
Tanti A; Micallef B; Serracino-Inglott A; Borg JJ
Expert Opin Drug Saf; 2017 Jan; 16(1):65-76. PubMed ID: 27732110
[TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions: classification, susceptibility and reporting.
Kaufman G
Nurs Stand; 2016 Aug; 30(50):53-63. PubMed ID: 27507394
[TBL] [Abstract][Full Text] [Related]
15. Nurses' spontaneous reporting of adverse drug reactions: expert review of routine reports.
Mendes D; Alves C; Batel Marques F
J Nurs Manag; 2014 Apr; 22(3):322-30. PubMed ID: 24754750
[TBL] [Abstract][Full Text] [Related]
16. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
[TBL] [Abstract][Full Text] [Related]
17. [Editorial: adverse drug reactions].
Taegtmeyer AB
Ther Umsch; 2015 Dec; 72(11-12):667. PubMed ID: 26654808
[No Abstract] [Full Text] [Related]
18. Veterinary pharmacovigilance. Part 2. Veterinary pharmacovigilance in practice -- the operation of a spontaneous reporting scheme in a European Union country -- the UK, and schemes in other countries.
Woodward KN
J Vet Pharmacol Ther; 2005 Apr; 28(2):149-70. PubMed ID: 15842305
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacovigiance: The spontaneous reporting system in Switzerland].
Schäublin M
Ther Umsch; 2015 Dec; 72(11-12):743-8. PubMed ID: 26654819
[TBL] [Abstract][Full Text] [Related]
20. Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works.
Santoro A; Genov G; Spooner A; Raine J; Arlett P
Drug Saf; 2017 Oct; 40(10):855-869. PubMed ID: 28735357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
